Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion type Assertion NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_head.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion description "[Here, we tested the hypothesis that chemokine gene therapy with fractalkine (FKN) induces an effective anti-neuroblastoma immune response amplified by targeted IL-2 using the anti-GD2 antibody ch14.18 fused with IL-2 (ch14.18-IL-2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion evidence source_evidence_literature NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion SIO_000772 15953676 NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion wasDerivedFrom befree-20140225 NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.
- NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_assertion wasGeneratedBy ECO_0000203 NP256241.RALY5TrjBLbGontxhjGmo-D-WyDET5G2K4clDC27C3vx8130_provenance.